Nexsen Limited (ASX:NXN)
0.2550
+0.0300 (13.33%)
At close: Jun 5, 2026
Nexsen Market Cap
Nexsen has a market cap or net worth of 51.05 million as of June 5, 2026.
Market Cap
51.05M
Enterprise Value
44.17M
Revenue
931.61K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.26
Market Cap Chart
Since October 14, 2025, Nexsen's market cap has decreased from 56.05M to 51.05M, a decrease of -8.93%. That is a compound annual growth rate of -13.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 51.05M | 59.38% |
| Dec 31, 2025 | 32.03M | -42.86% |
| Oct 14, 2025 | 56.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immutep | 75.16M |
| Cynata Therapeutics | 73.04M |
| Radiopharm Theranostics | 69.11M |
| LTR Pharma | 66.35M |
| Botanix Pharmaceuticals | 59.85M |
| Amplia Therapeutics | 59.03M |
| Entropy Neurodynamics | 53.85M |
| Neurizon Therapeutics | 45.52M |